257 related articles for article (PubMed ID: 19304275)
1. Oxidized phospholipids in control of inflammation and endothelial barrier.
Fu P; Birukov KG
Transl Res; 2009 Apr; 153(4):166-76. PubMed ID: 19304275
[TBL] [Abstract][Full Text] [Related]
2. Elevated truncated oxidized phospholipids as a factor exacerbating ALI in the aging lungs.
Ke Y; Karki P; Kim J; Son S; Berdyshev E; Bochkov VN; Birukova AA; Birukov KG
FASEB J; 2019 Mar; 33(3):3887-3900. PubMed ID: 30521374
[TBL] [Abstract][Full Text] [Related]
3. Oxidized Phospholipids in Healthy and Diseased Lung Endothelium.
Karki P; Birukov KG
Cells; 2020 Apr; 9(4):. PubMed ID: 32326516
[TBL] [Abstract][Full Text] [Related]
4. Amphipathic Helical Peptide L37pA Protects against Lung Vascular Endothelial Dysfunction Caused by Truncated Oxidized Phospholipids via Antagonism with CD36 Receptor.
Karki P; Li Y; Zhang CO; Ke Y; Promnares K; Birukova AA; Eggerman TL; Bocharov AV; Birukov KG
Am J Respir Cell Mol Biol; 2024 Jan; 70(1):11-25. PubMed ID: 37725486
[TBL] [Abstract][Full Text] [Related]
5. Lipid mediators in the regulation of endothelial barriers.
Karki P; Birukov KG
Tissue Barriers; 2018 Jan; 6(1):e1385573. PubMed ID: 29083949
[TBL] [Abstract][Full Text] [Related]
6. Oxidized Phospholipids in Control of Endothelial Barrier Function: Mechanisms and Implication in Lung Injury.
Karki P; Birukov KG
Front Endocrinol (Lausanne); 2021; 12():794437. PubMed ID: 34887839
[TBL] [Abstract][Full Text] [Related]
7. Truncated oxidized phospholipids exacerbate endothelial dysfunction and lung injury caused by bacterial pathogens.
Karki P; Zhang CO; Promnares K; Li Y; Ke Y; Birukova AA; Birukov KG
Cell Signal; 2023 Sep; 109():110804. PubMed ID: 37437826
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory profile of oxidized phospholipids.
Bochkov VN
Thromb Haemost; 2007 Mar; 97(3):348-54. PubMed ID: 17334500
[TBL] [Abstract][Full Text] [Related]
9. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans.
Leitinger N
Subcell Biochem; 2008; 49():325-50. PubMed ID: 18751917
[TBL] [Abstract][Full Text] [Related]
10. The regulation of inflammation by oxidized phospholipids.
Freigang S
Eur J Immunol; 2016 Aug; 46(8):1818-25. PubMed ID: 27312261
[TBL] [Abstract][Full Text] [Related]
11. Modified phospholipids as anti-inflammatory compounds.
Feige E; Mendel I; George J; Yacov N; Harats D
Curr Opin Lipidol; 2010 Dec; 21(6):525-9. PubMed ID: 20827191
[TBL] [Abstract][Full Text] [Related]
12. Reduction of myocardial ischaemia-reperfusion injury by inactivating oxidized phospholipids.
Yeang C; Hasanally D; Que X; Hung MY; Stamenkovic A; Chan D; Chaudhary R; Margulets V; Edel AL; Hoshijima M; Gu Y; Bradford W; Dalton N; Miu P; Cheung DY; Jassal DS; Pierce GN; Peterson KL; Kirshenbaum LA; Witztum JL; Tsimikas S; Ravandi A
Cardiovasc Res; 2019 Jan; 115(1):179-189. PubMed ID: 29850765
[TBL] [Abstract][Full Text] [Related]
13. Physiological effects of oxidized phospholipids and their cellular signaling mechanisms in inflammation.
Greig FH; Kennedy S; Spickett CM
Free Radic Biol Med; 2012 Jan; 52(2):266-80. PubMed ID: 22080084
[TBL] [Abstract][Full Text] [Related]
14. Aging-Related Accumulation of Truncated Oxidized Phospholipids Augments Infectious Lung Injury and Endothelial Dysfunction via Cluster of Differentiation 36-Dependent Mechanism.
Ke Y; Karki P; Li Y; Promnares K; Zhang CO; Eggerman TL; Bocharov AV; Birukova AA; Birukov KG
Cells; 2023 Jul; 12(15):. PubMed ID: 37566016
[TBL] [Abstract][Full Text] [Related]
15. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic effects of oxidized phospholipids.
Bochkov V; Gesslbauer B; Mauerhofer C; Philippova M; Erne P; Oskolkova OV
Free Radic Biol Med; 2017 Oct; 111():6-24. PubMed ID: 28027924
[TBL] [Abstract][Full Text] [Related]
17. The role of oxidized phospholipids in atherosclerosis.
Berliner JA; Leitinger N; Tsimikas S
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S207-12. PubMed ID: 19059906
[TBL] [Abstract][Full Text] [Related]
18. Oxidized phospholipids as triggers of inflammation in atherosclerosis.
Leitinger N
Mol Nutr Food Res; 2005 Nov; 49(11):1063-71. PubMed ID: 16270279
[TBL] [Abstract][Full Text] [Related]
19. The role of oxidized phospholipids in the development of disease.
Nie J; Yang J; Wei Y; Wei X
Mol Aspects Med; 2020 Dec; 76():100909. PubMed ID: 33023753
[TBL] [Abstract][Full Text] [Related]
20. Polar head groups are important for barrier-protective effects of oxidized phospholipids on pulmonary endothelium.
Birukova AA; Fu P; Chatchavalvanich S; Burdette D; Oskolkova O; Bochkov VN; Birukov KG
Am J Physiol Lung Cell Mol Physiol; 2007 Apr; 292(4):L924-35. PubMed ID: 17158600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
